Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
In an article published in July 9, 2009 issue of The New England Journal of Medicine, Dr. Daniel Clarke-Pearson, chair of the department of obstetrics and gynecology at…
Scott Nelson, MD, talks at the 2009 NAMC Conference in Santa Ana Pueblo New Mexico, about how physicians can better communicate with terminally ill patients. Reading: Shama ME,…
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some…
NEW YORK (Reuters Health) – Definitive chemoradiotherapy is an effective treatment than can be dispensed with no significant toxicity in elderly patients with locally advanced esophageal cancer, according…
A research team led by scientists at MD Anderson Cancer Center report that 2 specific common inheritedgenetic variations are associated with increased risk of lung cancer for smokers…
Levels of two proteins in a woman’s ovarian cancer are strongly associated with her likelihood of survival, a research team led by scientists at The University of Texas…
NEW YORK (Reuters Health) – The incidence of non-Hodgkin’s lymphoma (NHL) is increased somewhat in patients with diabetes, according to results of a meta-analysis published in Diabetes Care…
NEW YORK (Reuters Health) – The results of a case-control study suggest that the benefit of colonoscopy in preventing colorectal cancer deaths is largely limited to left-sided malignancies.…
NEW YORK (Reuters Health) – Results of a phase I trial suggest that intralesional transfer of plasmid interleukin (IL)-12 enhanced by electroporation for treatment of metastatic melanoma is…
NEW YORK (Reuters Health) – While prophylactic cranial irradiation can reduce the occurrence of brain metastases and improve survival in patients treated for extensive-disease small-cell lung cancer, it…
